Repligen (RGEN) Cash from Operations Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Repligen | 6.39 Bn | 5.41 Bn | 108.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.03% |
| Dec 31, 2025 | 11.57% |
| Sep 30, 2025 | 17.49% |
| Jun 30, 2025 | 11.32% |
| Mar 31, 2025 | 9.50% |
| Dec 31, 2024 | 17.26% |
| Sep 30, 2024 | 17.56% |
| Jun 30, 2024 | 18.85% |
| Mar 31, 2024 | 35.50% |
| Dec 31, 2023 | 39.23% |
| Sep 30, 2023 | 14.79% |
| Jun 30, 2023 | 42.03% |
| Mar 31, 2023 | 47.98% |
| Dec 31, 2022 | 32.39% |
| Sep 30, 2022 | 91.77% |
| Jun 30, 2022 | 74.65% |
| Mar 31, 2022 | 82.33% |
| Dec 31, 2021 | 90.96% |
| Sep 30, 2021 | 83.77% |
| Jun 30, 2021 | 28.94% |
| Mar 31, 2021 | 34.68% |
| Dec 31, 2020 | 34.71% |
| Sep 30, 2020 | 26.68% |
| Jun 30, 2020 | 17.67% |
| Mar 31, 2020 | 43.73% |
| Dec 31, 2019 | 58.75% |
| Sep 30, 2019 | 28.26% |
| Jun 30, 2019 | 50.27% |
| Mar 31, 2019 | 4.12% |
| Dec 31, 2018 | -4.42% |
| Sep 30, 2018 | 24.51% |
| Jun 30, 2018 | -7.48% |
| Mar 31, 2018 | -15.25% |
| Dec 31, 2017 | 16.05% |
| Sep 30, 2017 | -21.97% |
| Sep 30, 2016 | -1.18% |
| Jun 30, 2016 | 42.60% |
| Mar 31, 2016 | -35.92% |
| Dec 31, 2015 | 24.65% |
| Sep 30, 2015 | 42.15% |
| Jun 30, 2015 | 78.42% |